{
    "clinical_study": {
        "@rank": "15093", 
        "arm_group": [
            {
                "arm_group_label": "cilnidipine/valsartan", 
                "arm_group_type": "Experimental", 
                "description": "cilnidipine/valsartan tablet"
            }, 
            {
                "arm_group_label": "cilnidipine+valsartan", 
                "arm_group_type": "Active Comparator", 
                "description": "coadministration of cilnidipine and valsartan"
            }
        ], 
        "brief_summary": {
            "textblock": "A randomized, open-label, single dosing, two-way crossover clinical trial to compare the\n      safety/tolerability and pharmacokinetics of the combination of Cilnidipine 10mg and\n      Valsartan 160mg in comparison to each component coadministered in healthy male volunteers."
        }, 
        "brief_title": "A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination Tablet With Coadministration of Cilnidipine and Valsartan", 
        "condition": "Healthy Volunteers", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age between 20 and 40\n\n          -  Signed informed consent\n\n        Exclusion Criteria:\n\n          -  Has a history of hypersensitivity to IP ingredients\n\n          -  Hypertension or hyportension"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "54", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 10, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02088008", 
            "org_study_id": "ID_IDCV_1303"
        }, 
        "intervention": {
            "arm_group_label": [
                "cilnidipine/valsartan", 
                "cilnidipine+valsartan"
            ], 
            "intervention_name": "cinidipine, valsartan", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Cilnidipine", 
                "Valsartan"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 12, 2014", 
        "location": {
            "contact": {
                "last_name": "Kyungsang Yu"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Seoul National University Hospital"
            }, 
            "investigator": {
                "last_name": "Kyungsang Yu", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Open-label, Single Dosing, Two-way Crossover Clinical Trial to Compare the Safety/Tolerability and Pharmacokinetics of the Combination of Cilnidipine 10mg and Valsartan 160mg in Comparison to Each Component Coadministered in Healthy Male Volunteers", 
        "overall_contact": {
            "email": "yapark@ildong.com", 
            "last_name": "yoan park", 
            "phone": "82-2-526-3524"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Korea: Ministry of Food and Drug Safety", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "AUClast", 
                "safety_issue": "Yes", 
                "time_frame": "0~24hrs"
            }, 
            {
                "measure": "Cmax", 
                "safety_issue": "Yes", 
                "time_frame": "0~24hrs"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02088008"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "IlDong Pharmaceutical Co Ltd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "IlDong Pharmaceutical Co Ltd", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}